Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function

Biochemical and Biophysical Research Communications

Volumn 427, Issue 2, 2012, Pages 261-265

  Rydberg, Hanna A ^a   Carlsson, Nils ^a   Nordén, Bengt ^a  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Antimicrobial peptide; Arginine rich peptide; Cell penetrating peptide; Circular dichroism; Linear dichroism; Tryptophan

Indexed keywords

ARGININE; CELL PENETRATING PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TRYPTOPHAN;

ALPHA HELIX; ANTIMICROBIAL ACTIVITY; ARTICLE; CIRCULAR DICHROISM; CYTOTOXICITY; LINEAR DICHROISM; LIPID MEMBRANE; LIPID VESICLE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; ARGININE; CELL MEMBRANE; CIRCULAR DICHROISM; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; TRYPTOPHAN;

NEGIBACTERIA; POSIBACTERIA; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

EID: 84867888751     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.030     Document Type: Article

References (36)

1. Henriques S.T., Melo M.N., Castanho M. Cell-penetrating peptides and antimicrobial peptides: how different are they?. Biochem. J. 2006, 399:1-7.
2. Splith K., Neundorf I. Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur. Biophys. J. 2011, 40:387-397.
3. Palm C., Netzerea S., Hallbrink M. Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects. Peptides 2006, 27:1710-1716.
4. Nekhotiaeva N., Elmquist A., Rajarao G.K., Hallbrink M., Langel U., Good L. Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. FASEB J. 2004, 18:394-396.
5. Jung H.J., Jeong K.S., Lee D.G. Effective antibacterial action of tat (47-58) by increased uptake into bacterial cells in the presence of trypsin. J. Microbiol. Biotechnol. 2008, 18:990-996.
6. Takeshima K., Chikushi A., Lee K.K., Yonehara S., Matsuzaki K. Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J. Biol. Chem. 2003, 278:1310-1315.
7. Duchardt F., Ruttekolk I.R., Verdurmen W.P.R., Lortat-Jacob H., Burck J., Hufnagel H., Fischer R., van den Heuvel M., Lowik D., Vuister G.W., Ulrich A., de Waard M., Brock R. A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency. J. Biol. Chem. 2009, 284:36099-36108.
8. Zhang X.A., Oglecka K., Sandgren S., Belting M., Esbjorner E.K., Norden B., Graslund A. Dual functions of the human antimicrobial peptide LL-37-target membrane perturbation and host cell cargo delivery. Biochim. Biophys. Acta-Biomembr. 2010, 1798:2201-2208.
9. Wang Q., Hong G.Y., Johnson G.R., Pachter R., Cheung M.S. Biophysical properties of membrane-active peptides based on micelle modeling: a case study of cell-penetrating and antimicrobial peptides. J. Phys. Chem. B 2010, 114:13726-13735.
10. Shang D.J., Li X., Sun Y., Wang C., Sun L., Wei S., Gou M. Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, temporin-1ceb from chinese brown frog, Rana chensinensis. Chem. Biol. Drug Des. 2012, 79:653-662.
11. Staubitz P., Peschel A., Nieuwenhuizen W.F., Otto M., Gotz F., Jung G., Jack R.W. Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin. J. Pept. Sci. 2001, 7:552-564.
12. Nan Y.H., Park I.S., Hahm K.S., Shin S.Y. Antimicrobial activity, bactericidal mechanism and LPS-neutralizing activity of the cell-penetrating peptide pVEC and its analogs. J. Pept. Sci. 2011, 17:812-817.
13. Zhu W.L., Lan H.L., Park I.S., Kim J.I., Jin H.Z., Hahm K.S., Shin S.Y. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. Biochem. Biophys. Res. Commun. 2006, 349:769-774.
14. Bobone S., Piazzon A., Orioni B., Pedersen J.Z., Nan Y.H., Hahm K.S., Shin S.Y., Stella L. The thin line between cell-penetrating and antimicrobial peptides: the case of Pep-1 and Pep-1-K. J. Pept. Sci. 2011, 17:335-341.
15. Maiolo J.R., Ferrer M., Ottinger E.A. Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating epeptides. Biochim. Biophys. Acta-Biomembr. 2005, 1712:161-172.
16. Rydberg H.A., Matson M., åmand H.L., Esbjörner E.K., Nordén B. Effects of tryptophan content and backbone spacing on the uptake efficiency of cell-penetrating peptides. Biochemistry 2012, 51:5531-5539.
17. Deslouches B., Phadke S.M., Lazarevic V., Cascio M., Islam K., Montelaro R.C., Mietzner T.A. De nova generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob. Agents Chemother. 2005, 49:316-322.
18. Walrant A., Correia I., Jiao C.Y., Lequin O., Bent E.H., Goasdoue N., Lacombe C., Chassaing G., Sagan S., Alves I.D. Different membrane behaviour and cellular uptake of three basic arginine-rich peptides. Biochim. Biophys. Acta-Biomembr. 1808, 2011:382-393.
19. Strömstedt A.A., Pasupuleti M., Schmidtchen A., Malmsten M. Oligotryptophan-tagged antimicrobial peptides and the role of the cationic sequence. Biochim. Biophys. Acta-Biomembr. 2009, 1788:1916-1923.
20. Heitz F., Morris M.C., Divita G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br. J. Pharmacol. 2009, 157:195-206.
21. Chan D.I., Prenner E.J., Vogel H.J. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim. Biophys. Acta-Biomembr. 2006, 1758:1184-1202.
22. Blondelle S.E., Takahashi E., Dinh K.T., Houghten R.A. The antimicrobial activity of hexapeptides derived from synthetic combinatorial libraries. J. Appl. Bacteriol. 1995, 78:39-46.
23. Strom M.B., Rekdal O., Svendsen J.S. Antimicrobial activity of short arginine- and tryptophan-rich peptides. J. Pept. Sci. 2002, 8:431-437.
24. Nordén B., Rodger A., Dafforn T.R. Linear Dichroism and Circular Dichroism - A Textbook on Polarized-Light Spectroscopy 2010, RSC Publishing, Cambridge, UK.
25. Brahms S., Brahms J. Determination of protein secondary structure in solution by vacuum ultraviolet circular-dichroism. J. Mol. Biol. 1980, 138:149-178.
26. Kelly S.M., Jess T.J., Price N.C. How to study proteins by circular dichroism. BBA Proteins Proteom. 2005, 1751:119-139.
27. Matson M., Carlsson N., Beke-Somfai T., Nordén B. Spectral properties and orientation of voltage-sensitive dyes in lipid membranes. Langmuir 2012, 28:10808-10817.
28. Ardhammar M., Lincoln P., Norden B. Invisible liposomes: refractive index matching with sucrose enables flow dichroism assessment of peptide orientation in lipid vesicle membrane. Proc. Nat. Acad. Sci. USA 2002, 99:15313-15317.
29. Urban E., Nagy E., Pal T., Sonnevend A., Conlon J.M. Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-23) against anaerobic bacteria. Int. J. Antimicrob. Ag. 2007, 29:317-321.
30. Andra J., Jakovkin I., Grotzinger J., Hecht O., Krasnosdembskaya A.D., Goldmann T., Gutsmann T., Leippe M. Structure and mode of action of the antimicrobial peptide arenicin. Biochem. J. 2008, 410:113-122.
31. Yunes R.A. A circular-dichroism study of the structure of apis-mellifera melittin. Arch. Biochem. Biophys. 1982, 216:559-565.
32. Vanveen M., Georgiou G.N., Drake A.F., Cherry R.J. Circular-dichroism and fluorescence studies on melittin - effects of C-terminal modifications on tetramer formation and binding to phosphoipid-vesicles. Biochem. J. 1995, 305:785-790.
33. Drake A.F., Hider R.C. Structure of melittin in lipid bilayer membranes. Biochim. Biophys. Acta 1979, 555:371-373.
34. Dafforn T.R., Rajendra J., Halsall D.J., Serpell L.C., Rodger A. Protein fiber linear dichroism for structure determination and kinetics in a low-volume, low-wavelength couette flow cell. Biophys. J. 2004, 86:404-410.
35. Esbjörner E.K., Caesar C.E.B., Albinsson B., Lincoln P., Nordén B. Tryptophan orientation in model lipid membranes. Biochem. Biophys. Res. Commun. 2007, 361:645-650.
36. Svensson F.R., Lincoln P., Nordén B., Esbjörner E.K. Tryptophan orientations in membrane-bound gramicidin and melittin - a comparative linear dichroism study on transmembrane and surface-bound peptides. Biochim. Biophys. Acta-Biomembr. 1808, 2011:219-228.